SOD2 and breast cancer: We showed that MnSOD-K68-Ac promotes a transformation-permissive phenotype, and this signature can indeed be extended to a chemotherapy-resistant breast cancer cell model in a dose-dependent manner using cisplatin and doxorubicin.